A Study of a Dietary Supplement in Breastfeeding Mothers (WellFed)

Status Recruiting

Clinical Trial Summary

This is a randomized placebo-controlled study that aims to investigate the effect of a new maternal dietary supplement (protein hydrolysate/yeast beta-glucan combination) on mother and infant health.

Clinical Trial Description

N=140 healthy pregnant multiparous females aged between 18-49 years will be recruited to the study during pregnancy or up to 4-weeks postpartum, n=70 consuming the supplement and n=70 consuming a placebo. Following successful recruitment and screening, researchers will complete 2 study visits at the participant's home. Visit 1 marks the start of the intervention period and Visit 2 marks the end of the intervention period. Once the baseline data is completed (visit 1), the capsules will be provided to the mother. One capsule will be taken daily for 4 weeks. Capsules will be provided in convenient weekly tablet boxes. The return of used tablet boxes and counting missing capsules will monitor compliance. In addition, regular weekly contact will be maintained by phone and text message with participants to encourage adherence. In addition to the 2 study visits, all participants will receive an individual consultation with a lactation consultant to ensure breastfeeding techniques are appropriate and not a confounding factor in the breastmilk supply. Data collection will include: Anthropometric measurements include weight, height/length, and circumferences. Questionnaires will be used to collect birth data, demographic, lifestyle, breastfeeding and infant behavior, socio-economic status, health history, and gut health information. Dietary intakes will be assessed using an online 24-hour recall tool. Blood samples will be collected from mothers by a trained phlebotomist. A 5mL aliquot of breast milk will be collected from a full breast milk expression in the 24 hours prior to the research nurse visit using an electric breast pump. Mothers will record the volume of milk expressed and the remainder will be stored by the mother for the infant. for will use an electric breast pump for a full breast expression. The aliquot will be refrigerated until the research nurse visit. Mothers will collect a fecal sample from themselves and a fecal and urine sample from their baby in the 24 hours prior to the visit and will be stored in the freezer until the research nurse visit. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05924633
Study type	Interventional
Source	University College Dublin
Contact	Aifric O'Sullivan, PhD
Phone	+353 1 716 2824
Email	aifric.osullivan@ucd.ie
Status	Recruiting
Phase	N/A
Start date	June 6, 2023
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00579605` - Motivational Interviewing to Promote Sustained Breastfeeding	N/A
Completed	`NCT05655364` - Development of a Breastfeeding Supportive Mobile Application	N/A
Completed	`NCT03853850` - Using Mobile Phone Text Messaging System to Improve Exclusive Breastfeeding Rate in a Resource-poor Caribbean Island	N/A
Completed	`NCT03957941` - FamilyLink and Breastfeeding	N/A
Withdrawn	`NCT03709004` - Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum Depression	N/A
Completed	`NCT02958475` - Mother's Milk Messaging: Evaluation of a Bilingual Application (APP) to Support Initiation and Exclusive Breastfeeding in New Mothers	N/A
Active, not recruiting	`NCT05503069` - Community Interventions to Improve Breastfeeding	N/A
Not yet recruiting	`NCT02233439` - Double-blind, Placebocontrolled A Randomized Trial on the Efficacy of Herbal Galactogogues	N/A
Completed	`NCT01893736` - Professional Breastfeeding Support Intervention	N/A
Completed	`NCT02738957` - Effect of Prenatal Counseling on Breastfeeding Rates in Twins	N/A
Completed	`NCT00527956` - Facilitation and Barriers to Breastfeeding in the NICU	N/A
Completed	`NCT03655314` - Using the Electronic Health Record to Guide Management of Newborn Weight Loss	N/A
Completed	`NCT05562245` - Motivational Interviewing-Based Breastfeeding Education	N/A
Completed	`NCT05106634` - Evaluation of Breastfeeding Success and Self-Efficacy in Mothers Giving Birth Via Vaginal Delivery or Cesarean Section
Completed	`NCT05992753` - Mothers' Breast Milk Expression Experiences, Infant Feeding Attitudes and Perceived Social Support Levels
Recruiting	`NCT05250219` - Microchimeric Cell Tranfer From Mother to Child - Pilo Study
Recruiting	`NCT05213975` - Kinesio Taping Application After Cesarean Section	N/A
Recruiting	`NCT05371106` - Mycotoxins in Mothers Milk in Israel
Completed	`NCT03332108` - Novel Approach To Improving Lactation Support With Mobile Health Technology	N/A
Completed	`NCT02901665` - Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.